Brasília – The Minister of Health, Nísia Trindade, announced the investment of R$400 million for health research this Wednesday (31). Most of the money will be used to study genetic diseases.

The investment is part of the strategy to strengthen the SUS (Unified Health System). Nine public calls made by CNPq (National Council for Scientific and Technological Development) were also announced to conduct research.

The priority areas were defined by the APPMS (Research Priorities Agenda of the Ministry of Health) together with the technical areas of the Ministry’s secretariats. Each front will have 3 years to develop the research, with preliminary results expected from 2027.

Here are the areas for calls and investments:

  • Genomics and Precision Health – R$100 million;
  • Socially Determined Diseases – R$40 million;
  • Non-communicable Diseases and Conditions – R$40 million;
  • Pre-clinical trial for the SUS – R$32 million;
  • Preventing and Combating Misinformation – R$10 million;
  • Health Surveillance Research (HIV, AIDS and Tuberculosis) – R$6 million;
  • Health Technology Assessment Studies – R$2.9 million;
  • Evaluation of Health Policies, Programs, Projects – R$ 1 million;
  • Evidence Synthesis – R$1 million.

The R$400 million will be allocated by the end of the year. Immediately, R$234 million will be released to carry out the 9 calls. The organization hopes to make new calls to invest the remaining R$170 million in 2024.

Source: Poder 360

Leave a Reply

Tendência

Discover more from PharmaBR.News

Subscribe now to keep reading and get access to the full archive.

Continue reading